Position Your Brand at the Centre of Europe's CNS Biomarker Transformation
As biopharma continue to prioritise biomarkers to de-risk development programmes and improve clinical success, there has never been a better time to showcase your expertise, demonstrate your capabilities and establish your organisation as a trusted partner in Europe's rapidly evolving CNS biomarker landscape.
The Novel CNS Biomarkers Summit Europe brings together 60+ biomarker, translational, precision, mulitomics, neuroscience and clinical development leaders from Europe's leading biopharma and biotech companies who are actively investing in the next generation of fluid, imaging and digital biomarkers.
Whether you provide biomarker discovery platforms, bioanalytical services, imaging technologies, digital health solutions or translational expertise, this is your opportunity to position your organisation alongside the teams shaping the future of biomarker-driven CNS drug development and build relationships with the decision-makers driving these programmes forward.
What to Expect?
Meet the Teams Driving Biomarker Innovation
Connect face-to-face with biomarker, translational medicine, neuroscience and clinical development leaders who are actively integrating biomarkers across the CNS development pipeline and looking for technologies to strengthen their programmes.
Become a Partner in Biomarker-Driven Drug Development
As biomarkers become increasingly central to reducing late-stage clinical failures, demonstrate how your technologies and services can help biopharma generate robust biomarker data, improve decision-making and accelerate successful clinical development.
Showcase Solutions That Solve Critical Challenges
Position your expertise in front of organisations tackling assay harmonisation, biomarker validation, bioanalysis, digital biomarker implementation and regulatory readiness through tailored speaking, exhibition and branding opportunities.
Gain Insight into Biomarker Future Priorities
Hear directly from industry leaders about where investment is heading, the technologies they're adopting and the challenges they're looking to solve, helping you refine your commercial strategy and stay ahead of the market.
Where Europe's CNS Biomarker Leaders Find Their Next Partners
Europe's leading CNS biopharma are prioritising biomarker strategies to reduce clinical risk and accelerate development. Meet the scientists and decision-makers actively searching for new technologies, platforms and partners to support their programmes.
The Novel CNS Biomarkers Summit Europe will connect solution providers with biopharma teams seeking expertise across:
1
Fluid Biomarker Discovery & Bioanalytical Services
2
Imaging Biomarkers & Neuroimaging Technologies
3
Digital Biomarkers & Remote Monitoring Platforms
4
EEG & Electrophysiology Solutions
5
Biomarker Assay Development & Validation
6
AI, Data Analytics & Biomarker Informatics
7
Clinical Biomarker CRO & Translational Services
8
Sample Collection, Biobanking & Laboratory Technologies
Hear What Our Past Sponsors Have to Say
The diversity of topics and case studies stood out and very good coverage of both biofluids as well as imaging biomarkers
Director, Biomarkers, Passage Bio
It is a small meeting allowing for a lot of interaction. There was a lot of good discussion; very good presentations and plenty of time for interaction
Vice President, Biopharma & Business Development, Alamar Biosciences Inc.
*Testimonials from Hanson Wade's Fluid & Imaging Biomarkers in Neuroscience Summit
Audience Composition
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Hannah Martin
Partnerships Director
Stay Ahead of the CNS Biomarker Curve
As biopharma doubles down on biomarker-driven CNS development, position your brand at the centre of the conversations shaping the future.
Meet the Teams Driving Change
Build relationships with the biomarker, translational medicine and clinical development leaders making today's technology and partnership decisions.
Create a Presence That Can't Be Missed
Create a tailored sponsorship package that puts your expertise in front of Europe's most targeted CNS biomarker audience.